Synaptogenix Inc (SNPX)

[AlanF]

I’ve reviewed the preclinical work Alkon has published, and the journal article. I think the trial succeeds, with a pretty high conviction level. The KOL conference should be interesting, especially if the questioning is detailed.
In a month or two the results will be out and definitive.